Microgestin 1/20 Kit
Product Images NDC 51862-868

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Microgestin 1/20 (NDC 51862-868). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

FDA Label Image

2 (Image 02)

2 (Image 02)
This is a table that shows the lowest expected and typical failure rates of different contraceptive methods during the first year of continuous use. The failure rates are expressed as percentages of women experiencing an unintended pregnancy. The methods with the lowest expected failure rates are the implant (0.05%), female sterilization (0.5%), and male sterilization (0.1%). The methods with the highest expected failure rates are periodic abstinence (19%) and withdrawal (4%). The typical failure rates are generally higher than the expected rates and reflect the real-world effectiveness of the methods when they are used inconsistently or incorrectly.*
FDA Label Image

3 (Image 03)

3 (Image 03)
Cigarette smoking and oral contraceptive use can result in serious cardiovascular side effects. This risk particularly increases with age and heavy smoking habits (more than 15 cigarettes per day), and is particularly pronounced in women who are over the age of 35. Women who utilize oral contraceptives are advised to avoid smoking.*
FDA Label Image

4 (Image 04)

FDA Label Image

5 (Image 05)

5 (Image 05)
This is a table showing the annual number of birth-related or method-related deaths associated with control of fertility per 100,000 nonsterile women by fertility control method according to age. The methods of control and outcomes are listed in columns for different age groups. Some of the methods listed include no fertility control methods, oral contraceptives, condoms, diaphragm/spermicide, and periodic abstinence. The table has been adapted from H.W. Ory, Reference 41.*
FDA Label Image

6 (Image 06)

6 (Image 06)
Cigarette smoking and oral contraceptive use can lead to severe cardiovascular side effects, particularly in women over 35 years of age. Heavy smoking, defined as smoking 15 or more cigarettes per day, can further increase this risk. It is strongly recommended that women who use oral contraceptives should not smoke.*
FDA Label Image

7 (Image 07)

7 (Image 07)
The text describes instructions for taking Microgestin 1/20 birth control pills. The pills are all pale yellow in color, and the user can choose to start taking them on either Sunday or another day of their menstrual cycle. If starting on a day other than Sunday, the user should use the day label sticker that corresponds to the first day of their period. The text includes an example of how to use the stickers. The pills should be taken from left to right, following the arrow on the package.*
FDA Label Image

8 (Image 08)

8 (Image 08)
Cigarette smoking and oral contraceptive use can be a dangerous combination for women, increasing the risk of serious cardiovascular side effects, especially for those who are heavy smokers (15 or more cigarettes per day) and over 35 years of age. Therefore, it is strongly advised for women who use oral contraceptives not to smoke.*
FDA Label Image

9 (Image 09)

9 (Image 09)
This is a tabular representation of the annual number of deaths associated with fertility control methods per 100,000 non-sterile women, based on age groups. The table outlines different methods of control and associated outcomes, such as birth-related or method-related deaths. The age groups are divided into 15-19, 20-24, 25-29, 30-34, 35-39, and 40-44. The data includes numbers for no fertility control, oral contraceptives (for smokers and non-smokers), TUD, condoms, diaphragm/spermicide, and periodic abstinence.*
FDA Label Image

10 (Image 10)

10 (Image 10)
The text provides specific instructions for taking Microgestin 1/20 birth control pills. The pills are all pale yellow, and the user should take them from left to right, following the directions provided. The instructions also mention that if the user's period starts on a day other than Sunday, a day label sticker should be used to start the pill pack with the first day of the period.*
FDA Label Image

11 (Image 11)

FDA Label Image

12 (Image 12)

12 (Image 12)
Microgestin® 1/20 is a medication that contains Norethindrone Acetate and Ethinyl Estradiol in tablet form, and is used as a contraceptive to prevent pregnancy. The National Drug Code (NDC) for this medication is 5186286805.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.